Expression of estrogen receptor β,β2, and β5 messenger RNAs in human breast tissue

Cancer Research

Volumn 59, Issue 6, 1999, Pages 1175-1179

  Leygue, Etienne ^a   Dotzlaw, Helmut ^a   Watson, Peter H ^a   Murphy, Leigh C ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; RECEPTOR SUBTYPE;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; BREAST TUMOR; HUMAN; HUMAN CELL; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; BREAST; BREAST NEOPLASMS; ESTROGEN RECEPTOR BETA; FEMALE; HUMANS; MIDDLE AGED; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RNA, MESSENGER;

EID: 0033559575     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Vorherr, H. (ed.). Breast Cancer. Baltimore: Urban and Schwarzenherg Press, 1980.
2. Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J. M., Argos, P., and Chambon, P. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature, (Lond.) 320: 134-139, 1986.
3. Mosselman, S., Polman, J., and Dijkema, R. ER β: identification and characterization of a novel human estrogen receptor. FEBS Lett., 392: 49-53, 1996.
4. Ogawa, S., Inoue, S., Watanabe, T., Hiroi, H., Orimo, A., Hosoi, T., Ouchi, Y., and Muramatsu, M. The complete primary structure of human estrogen receptor β (hER β) and its heterodimerization with ER α in vivo and in vitro. Biochem. Biophys. Res. Commun., 243: 129-132, 1998.
5. Enmark, E., Pelto-Huikko, M., Grandien, K., Lagercrantz, S., Lagercrantz, J., Fried, G., Nordenskjold, M., and Gustafsson, J. A. Human estrogen receptor beta-gene structure, chromosomal localization, and expression pattern. J. Clin. Endocrinol. Metab., 82: 4258-4265, 1997.
6. Ponglikitmongkol, M., Green, S., and Chambon, P. Genomic organization of the human oestrogen receptor gene. EMBO J., 7: 3385-3388, 1988.
7. Evans, R. M. The steroid and thyroid receptor super-family. Science (Washington DC), 240: 889-895, 1988.
8. Kumar, V., Green, S., Stack, G., Berry, M., Jin, J. R., and Chambon, P. Functional domains of the human estrogen receptor. Cell, 51: 941-951, 1987.
9. Shibata, H., Spencer, T. E., Onate, S. A., Jenster, G., Tsai, S. Y., Tsai, M. J., and O'Malley, B. W. Role of co-activators and co-repressors in the mechanism of steroid/thyroid receptor action. Rec. Prog. Horm. Res., 52: 141-164, 1997.
10. Umayahara, Y., Kawamori, R., Watada, H., Imano, K., Iwama, N., Morishima, T., Yamasaki, Y., Kajimoto, Y., and Kamada, T. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem., 269: 16433-16442, 1994.
11. Paech, K., Webb, P., Kuiper, G. G., Nilsson, S., Gustafsson, J., Kushner, P. J., and Scanlan, T. S. Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites Science (Washington DC), 277: 1508-1510, 1997.
12. Watanabe, T., Inoue, S., Ogawa, S., Ishii, Y., Hiroi, H., Ikeda, K., Orimo, A., and Muramatsu, M. Agonistic effect of tamoxifen is dependent on cell type, ERE-promoter context, and estrogen receptor subtype: functional difference between estrogen receptors α and β. Biochem. Biophys. Res. Commun., 236: 140-145, 1997.
13. Cowley, S. M., Hoare, S., Mosselman, S., and Parker, M. G. Estrogen receptors α and β form heterodimers on DNA. J. Biol. Chem., 272: 19858-19862, 1997.
14. Murphy, L. C., Leygue, E., Dotzlaw, H., Douglas, D., Coults, A., and Watson, P. H. Estrogen receptor variants and mutations. Ann. Med., 29: 221-224, 1997.
15. Vladusic, E. A., Hornby, A. E., Guerra-Vladusic, F. K., and Lupu, R. Expression of estrogen receptor β messenger RNA variant in breast cancer. Cancer Res., 58: 210-214, 1998.
16. Lu, B., Leygue, E., Dotzlaw, H., Murphy, L. J., Murphy, L. C., and Watson, P. H. Estrogen receptor-β mRNA variants in human and murine tissues. Mol. Cell. Endocrinol., 138: 199-203, 1998.
17. Shupnik, M. A., Pitt, L. K., Soh, A. Y., Anderson, A., Lopes, M. B., and Laws, E. R., Jr. Selective expression of estrogen receptor α and β isoforms in human pituitary tumors. J. Clin. Endocrinol. Metab., 83: 3965-3972, 1998.
18. Fuqua, S. A. W., Fitzgerald, S. D., Chamness, G. C., Tandon, A. K., McDonnell, D. P., Nawaz, Z., O'Malley, B.W., and McGuire, W. L. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res., 51: 105-109, 1991.
19. Wang, Y., and Miksicek, R. J. Identification of a dominant negative form of the human estrogen receptor. Mol. Endocrinol., 5: 1707-1715, 1991.
20. Moore, J. T., McKee, D. D., Slentz-Kesler, K., Moore, L. B., Jones, S. A., Horne, E. L., Su, J. L., Kliewer, S. A., Lehman, J. M., and Willson, T. M. Cloning and characterization of human estrogen receptor β isoforms. Biochem. Biophys. Res. Commun., 247: 75-78, 1998.
21. Ogawa, S., Inoue, S., Watanabe, T., Hiroi, H., Orimo, A., Hosoi, T., Ouchi, Y., and Muramatsu, M. Molecular cloning and characterization of human estrogen receptor βcx: a potential inhibitor of estrogen action in human. Nucleic Acids Res., 26: 3505-3512, 1998.
22. Hiller, T., Snell, L., and Watson, P. H. Microdissection RT-PCR analysis of gene expression in pathologically defined frozen tissue sections. Biotechniques, 21: 38-44, 1996.
23. Elston, C. W., and Ellis, I. O. Pathological prognostic factors in breast cancer. Histopathology, 19: 403-410, 1991.
24. Dotzlaw, H., Alkhalaf, M., and Murphy, L. C. Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol. Endocrinol., 6: 773-785, 1992.
25. Leygue, E., Murphy, L. C., Kuttenn, F., and Watson, P. H. Triple primer PCR: a new way to quantity truncated mRNA expression. Am. J. Pathol., 148: 1097-1103, 1996.